ClinicalTrials.Veeva

Menu

Impact of Perioperative Anesthetic Management on Renal Cancer Progression.

M.D. Anderson Cancer Center logo

M.D. Anderson Cancer Center

Status

Withdrawn

Conditions

Perioperative Anesthetic
Renal Cancer

Study type

Observational

Funder types

Other

Identifiers

NCT06536244
2020-0380

Details and patient eligibility

About

The relationship between perioperative drugs, including preoperative medications, anesthetics, and analgesics, and postoperative outcomes in cancer patients is a complex and evolving field of study. Understanding how those medications might impact outcomes such as pain, acute kidney injury, and recurrence is crucial for optimizing perioperative care in renal cancer patients.

Full description

This retrospective study will investigate the association of perioperative drugs on short and long-term postoperative outcomes in patients undergoing kidney surgeries for renal cell carcinoma.

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Adult Participants (18 years of age or older)
  2. Participants having radical or partial nephrectomies with curative intent.

Exclusion criteria

  1. Patients with distant metastatic disease and those with multiple (more than 1) primary tumors at the time of the nephrectomy
  2. Biopsies
  3. Participants who had radiofrequency or microwave ablations.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems